{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:36:48Z","timestamp":1783129008561,"version":"3.54.6"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10555-013-9446-4","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T04:20:44Z","timestamp":1379564444000},"page":"707-721","source":"Crossref","is-referenced-by-count":20,"title":["Update on clinical and mechanistic aspects of paraneoplastic syndromes"],"prefix":"10.1007","volume":"32","author":[{"given":"David","family":"Tarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"key":"9446_CR1","doi-asserted-by":"crossref","unstructured":"Tarin, D., (2013). Role of the host stroma in cancer and its therapeutic significance. Cancer Metastasis Reviews. doi: 10.1007\/s10555-013-9438-4","DOI":"10.1007\/s10555-013-9438-4"},{"key":"9446_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus, F., Delattre, J. Y., Antoine, J. C., et al. (2004). Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1135\u20131140.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"9446_CR3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1474-4422(02)00135-7","volume":"1","author":"R Voltz","year":"2002","unstructured":"Voltz, R. (2002). Paraneoplastic neurological syndromes: An update on diagnosis, pathogenesis, and therapy. Lancet Neurology, 1, 294\u2013305.","journal-title":"Lancet Neurology"},{"key":"9446_CR4","unstructured":"Trousseau, A. (1872) Lectures on clinical medicine. Lecture XLV, delivered at the Hotel-Dieu, Paris, Volume 5 (Translated by Sir John Rose Cormack from the edition of 1868) (pp. 281\u2013332). Philadelphia: Lindsay and Blakiston"},{"key":"9446_CR5","first-page":"496","volume-title":"Paraneoplastic syndromes","author":"RE Darnell","year":"2011","unstructured":"Darnell, R. E., & Posner, J. B. (2011). Paraneoplastic syndromes (p. 496). Oxford: Oxford University Press."},{"key":"9446_CR6","first-page":"98","volume-title":"Recent advances in pathology","author":"JG Azzopardi","year":"1966","unstructured":"Azzopardi, J. G. (1966). Systemic effects of neoplasia. In C. V. Harrison (Ed.), Recent advances in pathology (pp. 98\u2013184). London: Churchill."},{"key":"9446_CR7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","volume":"85","author":"LC Pelosof","year":"2010","unstructured":"Pelosof, L. C., & Gerber, D. E. (2010). Paraneoplastic syndromes: An approach to diagnosis and treatment. Mayo Clinic Proceedings Mayo Clinic, 85, 838\u2013854.","journal-title":"Mayo Clinic Proceedings Mayo Clinic"},{"key":"9446_CR8","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2006-10-053736","volume":"110","author":"A Varki","year":"2007","unstructured":"Varki, A. (2007). Trousseau\u2019s syndrome: Multiple definitions and multiple mechanisms. Blood, 110, 1723\u20131729.","journal-title":"Blood"},{"key":"9446_CR9","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","volume":"280","author":"R Zhao","year":"2005","unstructured":"Zhao, R., Xing, S., Li, Z., et al. (2005). Identification of an acquired JAK2 mutation in polycythemia vera. The Journal of Biological Chemistry, 280, 22788\u201322792.","journal-title":"The Journal of Biological Chemistry"},{"key":"9446_CR10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00000441-200105000-00002","volume":"321","author":"LE Eubanks","year":"2001","unstructured":"Eubanks, L. E., McBurney, E., & Reed, R. (2001). Erythema gyratum repens. The American Journal of the Medical Sciences, 321, 302\u2013305.","journal-title":"The American Journal of the Medical Sciences"},{"key":"9446_CR11","first-page":"556","volume":"12","author":"M Gore","year":"2011","unstructured":"Gore, M., & Winters, M. E. (2011). Erythema gyratum repens: A rare paraneoplastic rash. The Western Journal of Emergency Medicine, 12, 556\u2013558.","journal-title":"The Western Journal of Emergency Medicine"},{"key":"9446_CR12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1365-2133.1999.03116.x","volume":"141","author":"SH Anderson","year":"1999","unstructured":"Anderson, S. H., Hudson-Peacock, M., & Muller, A. F. (1999). Malignant acanthosis nigricans: Potential role of chemotherapy. The British Journal of Dermatology, 141, 714\u2013716.","journal-title":"The British Journal of Dermatology"},{"key":"9446_CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0738-081X(93)90076-O","volume":"11","author":"LY Matsuoka","year":"1993","unstructured":"Matsuoka, L. Y., Wortsman, J., & Goldman, J. (1993). Acanthosis nigricans. Clinics in Dermatology, 11, 21\u201325.","journal-title":"Clinics in Dermatology"},{"key":"9446_CR14","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198712173172506","volume":"317","author":"DL Ellis","year":"1987","unstructured":"Ellis, D. L., Kafka, S. P., Chow, J. C., et al. (1987). Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. The New England Journal of Medicine, 317, 1582\u20131587.","journal-title":"The New England Journal of Medicine"},{"key":"9446_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01213299","volume":"32","author":"S Koyama","year":"1997","unstructured":"Koyama, S., Ikeda, K., Sato, M., et al. (1997). Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: An endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. Journal of Gastroenterology, 32, 71\u201377.","journal-title":"Journal of Gastroenterology"},{"key":"9446_CR16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/BOR.0b013e328359e780","volume":"25","author":"L Azar","year":"2013","unstructured":"Azar, L., & Khasnis, A. (2013). Paraneoplastic rheumatologic syndromes. Current Opinion in Rheumatology, 25, 44\u201349.","journal-title":"Current Opinion in Rheumatology"},{"key":"9446_CR17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","volume":"165","author":"CF Kuo","year":"2011","unstructured":"Kuo, C. F., See, L. C., Yu, K. H., et al. (2011). Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: A nationwide population study. The British Journal of Dermatology, 165, 1273\u20131279.","journal-title":"The British Journal of Dermatology"},{"key":"9446_CR18","first-page":"77","volume":"13","author":"W Zhang","year":"2009","unstructured":"Zhang, W., Jiang, S. P., & Huang, L. (2009). Dermatomyositis and malignancy: A retrospective study of 115 cases. European Review for Medical and Pharmacological Sciences, 13, 77\u201380.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"9446_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen, L., Nagaraju, K., Plotz, P., et al. (2005). Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. The Journal of Experimental Medicine, 201, 591\u2013601.","journal-title":"The Journal of Experimental Medicine"},{"key":"9446_CR20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/003591577707001206","volume":"70","author":"ML Ellison","year":"1977","unstructured":"Ellison, M. L. (1977). Cell differentiation and the biological significance of inappropriate tumour products. Proceedings of the Royal Society of Medicine, 70, 845\u2013850.","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"9446_CR21","first-page":"212","volume":"100","author":"JM Voyadzis","year":"2004","unstructured":"Voyadzis, J. M., Guttman-Bauman, I., Santi, M., et al. (2004). Hypothalamic hamartoma secreting corticotropin-releasing hormone. Case report. Journal of Neurosurgery, 100, 212\u2013216.","journal-title":"Journal of Neurosurgery"},{"key":"9446_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1026597816193","volume":"1","author":"V Grill","year":"2000","unstructured":"Grill, V., & Martin, T. J. (2000). Hypercalcemia of malignancy. Reviews in Endocrine & Metabolic Disorders, 1, 253\u2013263.","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"9446_CR23","first-page":"1551","volume":"29","author":"F Lumachi","year":"2009","unstructured":"Lumachi, F., Brunello, A., Roma, A., et al. (2009). Cancer-induced hypercalcemia. Anticancer Research, 29, 1551\u20131555.","journal-title":"Anticancer Research"},{"key":"9446_CR24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1152\/physrev.1996.76.1.127","volume":"76","author":"WM Philbrick","year":"1996","unstructured":"Philbrick, W. M., Wysolmerski, J. J., Galbraith, S., et al. (1996). Defining the roles of parathyroid hormone-related protein in normal physiology. Physiological Reviews, 76, 127\u2013173.","journal-title":"Physiological Reviews"},{"key":"9446_CR25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<398::AID-PATH496>3.0.CO;2-G","volume":"178","author":"LA Davidson","year":"1996","unstructured":"Davidson, L. A., Black, M., Carey, F. A., et al. (1996). Lung tumours immunoreactive for parathyroid hormone related peptide: Analysis of serum calcium levels and tumour type. The Journal of Pathology, 178, 398\u2013401.","journal-title":"The Journal of Pathology"},{"key":"9446_CR26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02739769","volume":"10","author":"P Komminoth","year":"1999","unstructured":"Komminoth, P., Heitz, P. U., & Roth, J. (1999). Human insulinomas: Clinical, cellular, and molecular aspects. Endocrine Pathology, 10, 269\u2013281.","journal-title":"Endocrine Pathology"},{"key":"9446_CR27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02739771","volume":"10","author":"RV Lloyd","year":"1999","unstructured":"Lloyd, R. V., Erickson, L. A., Nascimento, A. G., et al. (1999). Neoplasms causing nonhyperinsulinemic hypoglycemia. Endocrine Pathology, 10, 291\u2013297.","journal-title":"Endocrine Pathology"},{"key":"9446_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2796.1995.tb00907.x","volume":"238","author":"JB Sorensen","year":"1995","unstructured":"Sorensen, J. B., Andersen, M. K., & Hansen, H. H. (1995). Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. Journal of Internal Medicine, 238, 97\u2013110.","journal-title":"Journal of Internal Medicine"},{"key":"9446_CR29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau, J., & Rosenfeld, M. R. (2008). Paraneoplastic syndromes of the CNS. Lancet Neurology, 7, 327\u2013340.","journal-title":"Lancet Neurology"},{"key":"9446_CR30","volume-title":"Paraneoplastic syndromes","author":"R Darnell","year":"2011","unstructured":"Darnell, R., & Posner, J. (2011). Paraneoplastic syndromes. Oxford: Oxford University Press."},{"key":"9446_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/NRL.0b013e3181870aa2","volume":"15","author":"TB Toothaker","year":"2009","unstructured":"Toothaker, T. B., & Rubin, M. (2009). Paraneoplastic neurological syndromes: A review. The Neurologist, 15, 21\u201333.","journal-title":"The Neurologist"},{"key":"9446_CR32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/91.3.481","volume":"91","author":"JA Corsellis","year":"1968","unstructured":"Corsellis, J. A., Goldberg, G. J., & Norton, A. R. (1968). \u201cLimbic encephalitis\u201d and its association with carcinoma. Brain Journal of Neurology, 91, 481\u2013496.","journal-title":"Brain Journal of Neurology"},{"issue":"Pt 7","key":"9446_CR33","first-page":"1481","volume":"123","author":"SH Gultekin","year":"2000","unstructured":"Gultekin, S. H., Rosenfeld, M. R., Voltz, R., et al. (2000). Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. A Journal of Neurology, 123(Pt 7), 1481\u20131494.","journal-title":"A Journal of Neurology"},{"key":"9446_CR34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2990.1997.tb01323.x","volume":"23","author":"B Giometto","year":"1997","unstructured":"Giometto, B., Marchiori, G. C., Nicolao, P., et al. (1997). Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathology and Applied Neurobiology, 23, 468\u2013474.","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"9446_CR35","volume-title":"The cerebellum and its disorders","author":"J Hildebrand","year":"2002","unstructured":"Hildebrand, J., & Baleriaux. (2002). Cerebellar disorders in cancer. In M. Manto & M. Pandolfo (Eds.), The cerebellum and its disorders. Oxford: Oxford University Press."},{"key":"9446_CR36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s004010050460","volume":"91","author":"J Verschuuren","year":"1996","unstructured":"Verschuuren, J., Chuang, L., Rosenblum, M. K., et al. (1996). Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta neuropathologica, 91, 519\u2013525.","journal-title":"Acta neuropathologica"},{"key":"9446_CR37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","volume":"25","author":"F Graus","year":"2012","unstructured":"Graus, F., & Dalmau, J. (2012). Paraneoplastic neurological syndromes. Current Opinion in Neurology, 25, 795\u2013801.","journal-title":"Current Opinion in Neurology"},{"key":"9446_CR38","doi-asserted-by":"crossref","unstructured":"Sakai, K., Mitchell, D. J., Tsukamoto, T., et al. (1990). Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Annals of Neurology, 28, 692\u2013698.","DOI":"10.1002\/ana.410280515"},{"key":"9446_CR39","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp.2003.025171","volume":"75","author":"PM Candler","year":"2004","unstructured":"Candler, P. M., Hart, P. E., Barnett, M., et al. (2004). A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1411\u20131415.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"9446_CR40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11940-010-0066-9","volume":"12","author":"JE Greenlee","year":"2010","unstructured":"Greenlee, J. E. (2010). Treatment of paraneoplastic neurologic disorders. Current Treatment Options in Neurology, 12, 212\u2013230.","journal-title":"Current Treatment Options in Neurology"},{"key":"9446_CR41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/bmj.323.7308.334","volume":"323","author":"R Harbour","year":"2001","unstructured":"Harbour, R., & Miller, J. (2001). A new system for grading recommendations in evidence based guidelines. BMJ, 323, 334\u2013336.","journal-title":"BMJ"},{"key":"9446_CR42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/WNL.51.4.1146","volume":"51","author":"R Voltz","year":"1998","unstructured":"Voltz, R., Dalmau, J., Posner, J. B., et al. (1998). T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology, 51, 1146\u20131150.","journal-title":"Neurology"},{"key":"9446_CR43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","volume":"48","author":"H Suzuki","year":"2013","unstructured":"Suzuki, H., Asakawa, A., Amitani, H., et al. (2013). Cancer cachexia-pathophysiology and management. Journal of Gastroenterology, 48, 574\u2013594.","journal-title":"Journal of Gastroenterology"},{"key":"9446_CR44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MAJ.0b013e3181d9bb3b","volume":"340","author":"T Braik","year":"2010","unstructured":"Braik, T., Evans, A. T., Telfer, M., et al. (2010). Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review. The American Journal of the Medical Sciences, 340, 301\u2013308.","journal-title":"The American Journal of the Medical Sciences"},{"key":"9446_CR45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/mus.880090608","volume":"9","author":"YI Kim","year":"1986","unstructured":"Kim, Y. I. (1986). Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG. Muscle & Nerve, 9, 523\u2013530.","journal-title":"Muscle & Nerve"},{"key":"9446_CR46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11940-001-0047-0","volume":"3","author":"J Newsom-Davis","year":"2001","unstructured":"Newsom-Davis, J. (2001). Lambert\u2013Eaton myasthenic syndrome. Current Treatment Options in Neurology, 3, 127\u2013131.","journal-title":"Current Treatment Options in Neurology"},{"key":"9446_CR47","first-page":"1","volume":"3","author":"H Koike","year":"2013","unstructured":"Koike, H., & Sobue, G. (2013). Wide range of clinicopathological features in immune-mediated autonomic neuropathies. Cinical and Experimental Neuroimmunology, 3, 1\u201314.","journal-title":"Cinical and Experimental Neuroimmunology"},{"key":"9446_CR48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrneph.2010.171","volume":"7","author":"YH Lien","year":"2011","unstructured":"Lien, Y. H., & Lai, L. W. (2011). Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis. Nature Reviews Nephrology, 7, 85\u201395.","journal-title":"Nature Reviews Nephrology"},{"key":"9446_CR49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","volume":"70","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta, J., Juillard, L., Cochat, P., et al. (2009). Paraneoplastic glomerular diseases and malignancies. Critical Reviews in Oncology\/Hematology, 70, 39\u201358.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"9446_CR50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(71)92305-1","volume":"2","author":"MG Lewis","year":"1971","unstructured":"Lewis, M. G., Loughridge, L. W., & Phillips, T. M. (1971). Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet, 2, 134\u2013135.","journal-title":"Lancet"},{"key":"9446_CR51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(71)90999-8","volume":"1","author":"LW Loughridge","year":"1971","unstructured":"Loughridge, L. W., & Lewis, M. G. (1971). Nephrotic syndrome in malignant disease of non-renal origin. Lancet, 1, 256\u2013258.","journal-title":"Lancet"},{"key":"9446_CR52","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/0002-9343(76)90575-1","volume":"60","author":"RG Gagliano","year":"1976","unstructured":"Gagliano, R. G., Costanzi, J. J., Beathard, G. A., et al. (1976). The nephrotic syndrome associated with neoplasia: an unusual paraneoplastic syndrome. Report of a case and review of the literature. The American journal of medicine, 60, 1026\u20131031.","journal-title":"The American journal of medicine"},{"key":"9446_CR53","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","volume":"307","author":"DB Drachman","year":"1982","unstructured":"Drachman, D. B., Adams, R. N., Josifek, L. F., et al. (1982). Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. The New England journal of medicine, 307, 769\u2013775.","journal-title":"The New England journal of medicine"},{"key":"9446_CR54","doi-asserted-by":"crossref","unstructured":"Hohlefeld, R., Werkele, H., & Marx, A. (2012) The immuno-pathogenesis of myasthenia gravis, Chapter 3. In A. G Engel (Ed.), Myasthenia Gravis and Myasthenic Disorders, 2nd edn (pp. 60\u201384). Oxford: Oxford University Press","DOI":"10.1093\/med\/9780199738670.003.0003"},{"key":"9446_CR55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s00520-005-0825-4","volume":"13","author":"JA Zell","year":"2005","unstructured":"Zell, J. A., & Chang, J. C. (2005). Neoplastic fever: A neglected paraneoplastic syndrome. Supportive Care in Cancer, 13, 870\u2013877.","journal-title":"Supportive Care in Cancer"},{"key":"9446_CR56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10555-011-9326-8","volume":"31","author":"D Tarin","year":"2012","unstructured":"Tarin, D. (2012). Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance. Cancer Metastasis Reviews, 31, 21\u201339.","journal-title":"Cancer Metastasis Reviews"},{"key":"9446_CR57","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(71)91252-9","volume":"1","author":"FM Muggia","year":"1971","unstructured":"Muggia, F. M., & Ultmann, J. E. (1971). Glomerulonephritis or nephrotic syndrome in malignant lymphoma, reticulum-cell type. Lancet, 1, 805.","journal-title":"Lancet"},{"key":"9446_CR58","first-page":"CD007625","volume":"12","author":"B Giometto","year":"2012","unstructured":"Giometto, B., Vitaliani, R., Lindeck-Pozza, E., et al. (2012). Treatment for paraneoplastic neuropathies. Cochrane database of systematic reviews, 12, CD007625.","journal-title":"Cochrane database of systematic reviews"},{"key":"9446_CR59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/jvim.12026","volume":"27","author":"A Pakozdy","year":"2013","unstructured":"Pakozdy, A., Halasz, P., Klang, A., et al. (2013). Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody. Journal of Veterinary Internal Medicine \/ American College of Veterinary Internal Medicine, 27, 212\u2013214.","journal-title":"Journal of Veterinary Internal Medicine \/ American College of Veterinary Internal Medicine"},{"key":"9446_CR60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-3164.2003.00346.x","volume":"14","author":"MM Turek","year":"2003","unstructured":"Turek, M. M. (2003). Cutaneous paraneoplastic syndromes in dogs and cats: A review of the literature. Veterinary Dermatology, 14, 279\u2013296.","journal-title":"Veterinary Dermatology"},{"key":"9446_CR61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2011.10.022","volume":"57","author":"OG Fedorchuk","year":"2012","unstructured":"Fedorchuk, O. G., Pyaskovskaya, O. M., Skivka, L. M., et al. (2012). Paraneoplastic syndrome in mice bearing high-angiogenic variant of Lewis lung carcinoma: relations with tumor derived VEGF. Cytokine, 57, 81\u201388.","journal-title":"Cytokine"},{"key":"9446_CR62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.100.2.125","volume":"100","author":"B Lucke","year":"1954","unstructured":"Lucke, B., & Berwick, M. (1954). Catalase activity of liver and kidney in frogs with spontaneous renal carcinoma. The Journal of Experimental Medicine, 100, 125\u2013133.","journal-title":"The Journal of Experimental Medicine"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-013-9446-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-013-9446-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-013-9446-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T06:24:00Z","timestamp":1563949440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-013-9446-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":62,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["9446"],"URL":"https:\/\/doi.org\/10.1007\/s10555-013-9446-4","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]}}}